Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06491238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Study acronym: MG-Ex
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2026v6
  2. Primary completion date: Jun 2025 to Dec 2025 Completion date: Jul 2025 to Dec 2025v5 Show 1 more changeShow less
    • Completion date: Jul 2025 to Dec 2025
  3. Primary endpoints: 4 to 3 Secondary endpoints: 3 to 4v4 Show 1 more changeShow less
    • Secondary endpoints: 3 to 4

    See this version in full on ClinicalTrials.gov ↗

  4. Start date changed from estimate of Aug 2024 to Sep 16, 2024v3
  5. Start date: Jul 2024 to Aug 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, which is geared toward individuals with neurological disorders or injuries and led by Certified Exercise Physiologists (CEPs) at the HealthPartners Neuroscience Center. A total of 20 people with MG will be enrolled in this study and participate in a small group exercise program 3 times a week for 12 weeks. Participants will be randomized into two exercise groups: 1) Light intensity or 2) Moderate intensity. We hypothesize that light and moderate intensity exercise will be feasible, acceptable, and tolerable in adults with MG and that individuals in the light intensity exercise group will be able to achieve the same improvement in health outcomes as the moderate intensity group.
Trial Details
NCT Number NCT06491238
Lead Sponsor HealthPartners Institute
Conditions Myasthenia Gravis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov